Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
mis416 (1 trial)
Multiple Sclerosis (Phase 2)
Multiple Sclerosis, Chronic Progressive (Phase 2)
Sclerosis (Phase 2)
Trials (1 total)
Trial APIs (1 total)